Positron (OTCMKTS:POSC) Shares Down 6.2% – What’s Next?
Positron Co. (OTCMKTS:POSC – Get Free Report) shares fell 6.2% during mid-day trading on Friday . The company traded as low as $1.78 and last traded at $1.81. 34,998 shares traded hands during trading ...
Hosted on MSN1d
Siemens Healthineers and Cubresa sign agreement for BrainPET
Our company has built a foundation on delivering innovative, high-quality PET scanners to our customers worldwide, and the ...
Hosted on MSN15h
Artera partners with Tempus to expand AI cancer test access
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...
BioSpace4d
Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...
Radiopharm announces publication of clinical trial data highlighting RAD 101
Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...